Beam Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
78.31
|
|
Average Rating
|
4.36
|
|
# Strong Buys
|
9
|
|
# Buys
|
1
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.31
|
-1.56
|
-0.25
|
-19.08%
|
|
2022-06-30
|
-1.08
|
-1.02
|
0.06
|
5.56%
|
|
2022-03-31
|
-1.32
|
-1.01
|
0.31
|
23.48%
|
|
2021-12-31
|
-1.03
|
-0.95
|
0.08
|
7.77%
|
|
2021-09-30
|
-0.74
|
-0.42
|
0.32
|
43.24%
|
|
2021-06-30
|
-0.65
|
-1.23
|
-0.58
|
-89.23%
|
|
2021-03-31
|
-0.74
|
-3.35
|
-2.61
|
-352.70%
|
|
2020-12-31
|
-0.67
|
-1.69
|
-1.02
|
-152.24%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.59
|
|
2021-12-31
|
-5.95
|
|
2020-12-31
|
-4.10
|
|
2019-12-31
|
-6.36
|